Clinical Trials
Closed
Phase
Accrual
18%
SWOG Clinical Trial Number
S9805
Phase II Study of Tandem High Dose Melphalan Supported, by Peripheral Blood Stem Cell Support in Waldenstrom’s Macroglobulinemia (WM).
Activated
09-01-1998
Closed
05-01-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9717
Evaluation of Intravenously Administered Tirapazamine Plus Cisplatin in Cervical Cancer, Phase II.
Research Committee(s)
Gynecologic Cancer
Activated
08-15-1998
Closed
08-15-2000
Closed
Phase
Accrual
75%
Published
SWOG Clinical Trial Number
S9803
The Evaluation of Gemcitabine (Gemzar®) in Resistant and Relapsing Multiple Myeloma, Phase II
Activated
08-15-1998
Closed
12-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9832
Enhancing Well-Being During Breast Cancer Recurrence
Research Committee(s)
Breast Cancer
Activated
07-15-1998
Closed
11-15-2002
Closed
Phase
Accrual
18%
SWOG Clinical Trial Number
S9624
Evaluation of Ifosfamide/Mesna for Aggressive Meningeal Tumors (Malignant Meningioma, Hemangiopericytoma and Primary Nervous System Sarcoma), Phase II Study.
Research Committee(s)
Brain Cancer
Activated
07-01-1998
Closed
10-01-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9718
A Phase II Trial of Gemcitabine Plus Cisplatin in Patients With Extensive Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
07-01-1998
Closed
06-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9713
A Phase II Trial of Cisplatin/Etoposide and Concurrent, Radiotherapy Followed by Paclitaxel/Carboplatin Consolidation For Limited Stage Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
07-01-1998
Closed
08-01-1999
Open
Phase
SWOG Clinical Trial Number
S9808
Long Term Follow-Up Protocol: An Administrative Tool.
Research Committee(s)
Other
Activated
06-15-1998
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9802
A Phase II Trial of Gemcitabine in Advanced Soft Tissue Sarcomas
Activated
05-01-1998
Closed
03-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9626
Closed
Phase
Accrual
49%
Published
SWOG Clinical Trial Number
S9635
A Phase II Trial of 5-fluorouracil Plus 776C85 in Patients With Advanced Resistant Colorectal Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
04-01-1998
Closed
09-15-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9801
Evaluation of Gemcitabine - Cisplatin Combination Chemotherapy in Esophageal Carcinoma.
Activated
04-01-1998
Closed
06-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9720
Phase II Trial of Paclitaxel and Carboplatin with Amifostine in Advanced Recurrent or Refractory Endometrial Adenocarcinoma
Research Committee(s)
Gynecologic Cancer
Activated
02-15-1998
Closed
07-15-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9712
Phase II Trial of Concurrent Carboplatin/VP-16 and Radiation Followed by Paclitaxel (Taxol®) For Poor-Risk Stage III Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
02-15-1998
Closed
06-01-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9800
A Phase II Pilot Trial of CHOP Followed by Rituximab Chimeric Monoclonal Anti-CD20 Antibody for Treatment of Newly Diagnosed Follicular Non-Hodgkin’s Lymphomas
Research Committee(s)
Lymphoma
Activated
02-15-1998
Closed
11-15-1998
Closed
Phase
Accrual
1%
SWOG Clinical Trial Number
S9631
A Cross-Sectional Study to Estimate the Incidence of Endometrial Pathology in Women Receiving Tamoxifen on SWOG-9313 (INT-0137, CALGB 9394, NCCTG 93-30-51)
Research Committee(s)
Breast Cancer
Activated
02-01-1998
Closed
03-01-2000
Closed
Phase
Accrual
72%
Published
SWOG Clinical Trial Number
S9708
Evaluation of Gemcitabine (Gemzar®) in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN).
Activated
12-01-1997
Closed
03-01-1999
Closed
Phase
Accrual
10%
SWOG Clinical Trial Number
SWOG-9507
A Single Arm Phase II Study to Determine the Safety and Efficacy of 4-HPR N-(4-Hydroxyphenyl) Retinamide for Treating Oral Intraepithelial Neoplasia.
Activated
12-01-1997
Closed
03-01-2000
Closed
Phase
Accrual
62%
Published
SWOG Clinical Trial Number
S9701
Phase III Randomized Trial of 12 Months VS 3 Months of Paclitaxel in Patients with Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer Who Attain a Clinically Defined Complete Response (CR) Following Platinum/Paclitaxel-Based Chemotherapy (Intergroup)
Research Committee(s)
Gynecologic Cancer
Activated
11-15-1997
Closed
12-01-2001
Closed
Phase
Accrual
13%
SWOG Clinical Trial Number
S9719
Clonal Hematopoiesis as a Marker of Genetic Damage Pilot Study Following Adjuvant Chemotherapy for Breast Cancer: Pilot Study to Evaluate Incidence, Ancillary to S9623
Research Committee(s)
Breast Cancer
Activated
10-15-1997
Closed
02-01-2001